It is therefore of limited use in the treatment of rare cases of SM that show imatinib-sensitive KIT mutation (F522C, K5091, V560G, V559G, and del419) [29,30], without the KIT D816V mutation or with its unknown status [30,31]. The gene discussed is KIT; the disease is systemic mastocytosis.